1. Home
  2. CNTA vs WULF Comparison

CNTA vs WULF Comparison

Compare CNTA & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • WULF
  • Stock Information
  • Founded
  • CNTA 2020
  • WULF 1952
  • Country
  • CNTA United Kingdom
  • WULF United States
  • Employees
  • CNTA N/A
  • WULF N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • WULF EDP Services
  • Sector
  • CNTA Health Care
  • WULF Technology
  • Exchange
  • CNTA Nasdaq
  • WULF Nasdaq
  • Market Cap
  • CNTA 2.3B
  • WULF 2.6B
  • IPO Year
  • CNTA 2021
  • WULF 1995
  • Fundamental
  • Price
  • CNTA $16.46
  • WULF $5.96
  • Analyst Decision
  • CNTA Strong Buy
  • WULF Strong Buy
  • Analyst Count
  • CNTA 8
  • WULF 9
  • Target Price
  • CNTA $23.71
  • WULF $7.97
  • AVG Volume (30 Days)
  • CNTA 470.8K
  • WULF 32.1M
  • Earning Date
  • CNTA 11-12-2024
  • WULF 11-12-2024
  • Dividend Yield
  • CNTA N/A
  • WULF N/A
  • EPS Growth
  • CNTA N/A
  • WULF N/A
  • EPS
  • CNTA N/A
  • WULF N/A
  • Revenue
  • CNTA $6,853,000.00
  • WULF $128,351,000.00
  • Revenue This Year
  • CNTA N/A
  • WULF $110.37
  • Revenue Next Year
  • CNTA N/A
  • WULF $106.76
  • P/E Ratio
  • CNTA N/A
  • WULF N/A
  • Revenue Growth
  • CNTA N/A
  • WULF 131.22
  • 52 Week Low
  • CNTA $7.38
  • WULF $1.36
  • 52 Week High
  • CNTA $18.97
  • WULF $9.30
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 50.86
  • WULF 47.83
  • Support Level
  • CNTA $14.61
  • WULF $5.82
  • Resistance Level
  • CNTA $17.65
  • WULF $6.66
  • Average True Range (ATR)
  • CNTA 1.08
  • WULF 0.52
  • MACD
  • CNTA -0.10
  • WULF 0.07
  • Stochastic Oscillator
  • CNTA 56.74
  • WULF 58.58

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. The company's primary focus is supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. The company's primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

Share on Social Networks: